Stock RHONEMA RHONE MA HOLDINGS
Add to a list
To use this feature you must be a member
Log inSign up

Financials Rhone Ma Holdings

Equities

RHONEMA

MYL5278OO006

Pharmaceuticals

End-of-day quote BURSA MALAYSIA
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
0.68 MYR +0.74% Intraday chart for Rhone Ma Holdings -0.73% -1.45%
05-15 Rhone Ma's Profit Edges Up in Q1 MT
05-14 Rhone Ma Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 148.6 150.4 152.6 150.4 - -
Enterprise Value (EV) 1 148.6 150.4 152.6 150.4 150.4 150.4
P/E ratio 18.5 x 15.9 x 17.2 x 11 x 10.8 x 10.3 x
Yield - 2.94% 2.9% 2.94% 3.24% 3.53%
Capitalization / Revenue - 0.76 x 0.75 x 0.7 x 0.67 x 0.64 x
EV / Revenue - 0.76 x 0.75 x 0.7 x 0.67 x 0.64 x
EV / EBITDA - 6.24 x 6.53 x 6.24 x 6.04 x 5.85 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - 0.98 x - - - -
Nbr of stocks (in thousands) 200,860 221,226 221,226 221,226 - -
Reference price 2 0.7400 0.6800 0.6900 0.6800 0.6800 0.6800
Announcement Date 22/02/22 21/02/23 20/02/24 - - -
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 198.2 203.1 214.4 224.5 235.4
EBITDA 1 - 24.12 23.38 24.1 24.9 25.7
EBIT - 20.37 - - - -
Operating Margin - 10.28% - - - -
Earnings before Tax (EBT) 1 - 19.05 18.51 19.2 20.2 21.2
Net income 1 11.27 12.74 12.09 13.7 14 14.7
Net margin - 6.43% 5.95% 6.39% 6.24% 6.24%
EPS 2 0.0401 0.0428 0.0401 0.0620 0.0630 0.0660
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - 0.0200 0.0200 0.0200 0.0220 0.0240
Announcement Date 22/02/22 21/02/23 20/02/24 - - -
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - 8.95% - - 7.3% -
ROA (Net income/ Total Assets) - 6.14% - - - -
Assets 1 - 207.6 - - - -
Book Value Per Share - 0.6900 - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 22/02/22 21/02/23 20/02/24 - - -
1MYR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Rhone Ma Holdings

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.68 MYR
Average target price
0.7 MYR
Spread / Average Target
+2.94%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
RHONE MA HOLDINGS Stock Rhone Ma Holdings
-1.45% 31.89M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 224B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. RHONEMA Stock
  4. Financials Rhone Ma Holdings